Utopia Pharmaceuticals CEO Met with Abia State Governor to Discuss Pharmaceutical Investment in Nigeria
As part of Utopia Pharmaceuticals' strategic expansion across Africa, Dr. Saied Kamel, Chief Executive Officer of Utopia Pharmaceuticals, met with His Excellency Dr. Alex Otti, Governor of Abia State, Federal Republic of Nigeria, to discuss opportunities for strengthening pharmaceutical investment and industrial cooperation.
The meeting focused on Utopia's proposed pharmaceutical manufacturing facility in Abia State. The discussions highlighted the project's potential to transfer technology, localize pharmaceutical manufacturing, strengthen local production capabilities, and contribute to healthcare security across Nigeria and West Africa.
Dr. Saied Kamel emphasized that Utopia's vision extended beyond exporting Egyptian pharmaceutical products to building sustainable strategic partnerships that supported industrial development, created employment opportunities, and delivered long-term value to African economies through the transfer of Egyptian expertise in pharmaceutical manufacturing.
Governor Dr. Alex Otti expressed his strong support for the initiative and reaffirmed Abia State's commitment to attracting high-value investments while providing a favorable environment for the successful implementation of the project.
Utopia Pharmaceuticals expressed its sincere appreciation to His Excellency Governor Alex Otti for his warm hospitality and valuable support. The company also thanked Mr. Eze Abosital Gift Chibuzor Chinyere for his efforts in strengthening this collaboration.
The meeting marked another important milestone in Utopia Pharmaceuticals' commitment to expanding its presence across Africa and supporting the development of a sustainable pharmaceutical industry that enhanced regional healthcare and economic growth

Utopia Pharmaceuticals Welcomes High-Level Delegation from Abia State, Nigeria to Strengthen Pharmaceutical Manufacturing Cooperation and Technology Transfer
Utopia Pharmaceuticals welcomed a high-level delegation from Abia State, Federal Republic of Nigeria, headed by His Royal Majesty King Apostle Chibuzor Gift Chinyere (The Okwuorie One), during an official visit to the company’s advanced industrial facilities in Egypt.
The visit was held under the guidance and leadership of Dr. Saied Kamel, Chairman of Utopia Pharmaceuticals, as part of the company’s vision to strengthen pharmaceutical and industrial cooperation among African countries, support the localization of pharmaceutical manufacturing, and promote technology transfer across the continent.
During the visit, the delegation toured Utopia’s manufacturing facilities, including modern production lines, quality control laboratories, and research & development centers. The delegation praised the company’s advanced industrial capabilities, modern technologies, and quality systems implemented in accordance with international standards.
Dr. Saied Kamel emphasized the importance of strengthening African partnerships in the pharmaceutical sector, highlighting that Utopia prioritizes the transfer of expertise and technology, development of human capabilities, and supporting pharmaceutical security across Africa.
Discussions focused on opportunities for cooperation in pharmaceutical technology transfer, technical training, and establishing joint pharmaceutical manufacturing projects in Nigeria, in addition to supporting access to treatments for priority health challenges across Africa, including malaria and chronic diseases.
At the conclusion of the visit, both sides agreed to continue discussions, with Utopia Pharmaceuticals welcoming the official invitation to visit Abia State, Nigeria, to explore future investment opportunities and strategic partnerships in the pharmaceutical sector.
Both parties reaffirmed their commitment to building a successful African cooperation model that contributes to advancing pharmaceutical manufacturing, knowledge transfer, and improving healthcare quality across the continent

Utopia Pharmaceuticals Welcomes Danish Healthcare Delegation to Strengthen Cooperation and Partnerships
Utopia Pharmaceuticals was honored to welcome a distinguished Danish healthcare delegation to its manufacturing facility  as part of a visit organized by *Denmark in Egypt – Trade Council*.
The visit reflects the growing cooperation between *Utopia Pharmaceuticals, led by **Dr. Saied Kamel, CEO, and the **Embassy of Denmark in Egypt, led by **H.E. Lars Bo Møller, Ambassador of Denmark to Egypt*, with a shared vision to strengthen healthcare partnerships and explore future collaboration opportunities between Egypt and Denmark.
The delegation included representatives from leading Danish healthcare organizations, including *Medicoindustrien, UV Medico, Contura International, and Evnia*.
During the visit, the delegation toured *Utopia Pharmaceuticals’ manufacturing facilities*, including production areas, warehousing infrastructure, and Quality Control laboratories, gaining insight into the company’s advanced production lines, quality systems, and commitment to applying the latest international standards in pharmaceutical manufacturing.
We look forward to building on this cooperation and exploring new opportunities that support healthcare innovation and development

Strategic Memorandum of Understanding Signed Between Pharmalagasy S.A. (Madagascar) and Utopia Pharmaceuticals (Egypt) to Strengthen Pharmaceutical and Industrial Cooperation
In a significant step toward strengthening healthcare and industrial cooperation between the Republic of Madagascar and the Arab Republic of Egypt, Pharmalagasy S.A., the national pharmaceutical manufacturing company of Madagascar, and Utopia Pharmaceuticals, one of Egypt’s leading pharmaceutical manufacturers, have signed a Strategic Memorandum of Understanding (MoU) to establish a long-term partnership in pharmaceutical manufacturing, technology transfer, research and development, herbal medicines, nutritional supplements, and public health initiatives.
The partnership aims to foster collaboration in pharmaceutical production, technical knowledge exchange, scientific research and innovation, and the development of herbal and nutritional healthcare products. It also seeks to support public health programs and strengthen local capacities, contributing to improved access to high-quality medicines for the people of Madagascar and the broader African region.
The Memorandum of Understanding was signed during the official visit of the Pharmalagasy delegation to the Arab Republic of Egypt, in the presence of:
● Mrs. Hanitrinialasoa Rajohnson, General Manager, Pharmalagasy S.A., Madagascar.
● Mr. Jesiharison Panoel Andriatsarafara, World Bank Consultant and Strategic Advisor for the Restructuring and Development Program of Pharmalagasy S.A.
● Dr. Elsaied Kamel, Chairman of Utopia Pharmaceuticals, Egypt.
Both parties emphasized that this agreement marks the beginning of a strategic partnership aimed at supporting pharmaceutical localization, strengthening health security across Africa, and promoting the exchange of technology and expertise in line with the African Union’s vision for greater pharmaceutical self-sufficiency.
The partnership also reflects Egypt’s growing role as a regional hub for pharmaceutical manufacturing and innovation and highlights Utopia Pharmaceuticals’ commitment to expanding its presence across Africa. Guided by the belief that the future of the African pharmaceutical industry lies in collaboration, knowledge sharing, and technology transfer, this initiative seeks to improve public health outcomes while contributing to sustainable economic development throughout the continent

Utopia Pharma Welcomes High-Level Delegation from Rwanda FDA to Strengthen Pharmaceutical Cooperation Between Egypt and Rwanda
Utopia Pharma welcomed a high-level delegation from the Republic of Rwanda headed by *Prof. Emile Bienvenu, Director General of the Rwanda Food and Drugs Authority (Rwanda FDA), accompanied by **H.E. Ambassador Dan Munyuza, Ambassador of the Republic of Rwanda to the Arab Republic of Egypt*, as part of ongoing efforts to strengthen pharmaceutical cooperation and expand strategic partnerships between Egypt and African countries.
The delegation was received by *Dr. Saied Kamel, Chairman of Utopia Pharma*, and was accompanied during the visit by representatives from the Egyptian Drug Authority and the Embassy of the Republic of Rwanda in Cairo, including:
* Mr. Mahmoud El-Tayeb – Chief of Protocol, Embassy of the Republic of Rwanda in Cairo.
* Dr. Adham Saber – Member of the General Administration of Public Relations and International Cooperation, Egyptian Drug Authority.
* Dr. Radwa Hussein Sayed – Pharmaceutical Products Follow-up Team Leader, National and Strategic Projects Support Unit, Investment Support and Local Manufacturing Localization Administration, Egyptian Drug Authority.
* Dr. Ibrahim Salah El-Din – Data Analytics Unit, Investment Support and Local Manufacturing Localization Administration, Egyptian Drug Authority.
* Dr. Ahmed Gadallah Mahfouz – Head of the Veterinary Pharmaceutical Inspection Unit and Inspection Team Leader, Egyptian Drug Authority.
During the visit, the delegation toured Utopia Pharma’s manufacturing facilities, reviewing the company’s advanced production lines, quality management systems, and pharmaceutical manufacturing standards implemented in accordance with international best practices. The delegation was also introduced to Utopia’s manufacturing capabilities and its strategic expansion plans across African markets.
The delegation praised the company’s state-of-the-art manufacturing infrastructure, robust quality systems, and high-quality pharmaceutical products, emphasizing their potential contribution to addressing healthcare needs in Rwanda and supporting access to essential medicines.
Utopia Pharma remains committed to supporting Egypt’s vision of expanding pharmaceutical exports and strengthening its presence across Africa by delivering high-quality medicines, sharing industrial expertise, and contributing to greater pharmaceutical self-sufficiency throughout the continent

Utopia Pharmaceuticals proudly participated in the First International Scientific Conference of the Faculty of Pharmacy, Zagazig University, held under the theme “Research Meets Market Needs.”
The conference brought together a distinguished group of academic experts, researchers, and pharmaceutical industry leaders, aiming to strengthen the integration between scientific research and the pharmaceutical industry, and to promote innovation that supports market needs and healthcare development.
The event highlighted the critical role of applied scientific research as a key driver for economic growth and industrial advancement, emphasizing the importance of transforming research outcomes into practical pharmaceutical solutions, innovative products, and sustainable projects.
Utopia Pharmaceuticals’ participation reflects its strong commitment to supporting scientific research and fostering effective collaboration between academia and industry, contributing to the development of the pharmaceutical sector and improving healthcare quality.
Dr. Saied Kamel, CEO of Utopia Pharmaceuticals, participated in the conference as an invited speaker, where he shared insights on the importance of bridging the gap between research and industry, and highlighted the role of the private sector in supporting innovation and transforming scientific knowledge into real economic value.
The conference also featured a series of specialized scientific sessions covering the latest advancements in pharmaceutical sciences, including drug development, clinical research, biotechnology, and sustainable pharmaceutical practices.
Utopia Pharmaceuticals continues to support initiatives that connect research with real-world applications, believing that the future of healthcare begins when knowledge is transformed into impactful solutions

 Investing in People, Empowering the Future
At Utopia Pharma, we believe that our people are our greatest asset. That's why we are proud to celebrate the successful graduation of a group of our talented team members from the MBA Program, fully sponsored by Utopia Pharma as part of our ongoing commitment to employee development and leadership excellence.
This achievement was realized under the vision and supervision of Dr. Saied Kamel, CEO of Utopia Pharma, whose commitment to continuous learning and talent development continues to drive our culture of growth and innovation.
The program reflects our dedication to fostering future leaders and equipping our teams with the knowledge, strategic thinking, and leadership skills needed to shape the future of healthcare.
We extend our sincere congratulations to all graduates and our appreciation to the Arab Academy for Science, Technology & Maritime Transport for their valued collaboration in delivering this distinguished educational journey.
Together, we continue to invest in knowledge, develop talent, and build a stronger future.
#UtopiaPharma #EmployeeDevelopment #LeadershipDevelopment #MBA

A recent Egyptian study reveals that the rate of blood pressure control has increased to 44.2%, compared to only 8% three decades ago.
The Egyptian Society of Hypertension, headed by Professor Mohamed Mohsen Ibrahim, Professor of Cardiology at Kasr Al-Ainy Faculty of Medicine, along with Professor Wafaa El-Arousy, Professor of Cardiology at Kasr Al-Ainy Faculty of Medicine and Treasurer of the Egyptian Society of Hypertension, announced the results of the “Blood Pressure Control Rate in Egypt 2025” study. The study showed that the rate of blood pressure control among Egyptian patients has risen to 44.2%, compared to only 8% in the last national study conducted in 1995 as part of the National Hypertension Project (NHP).
The study results were announced during the 28th Annual Conference of the Egyptian Society of Hypertension, held in Cairo on June 3rd and 4th, attended by leading cardiology and hypertension professors, researchers, and healthcare specialists.
These findings represent a significant development, reflecting notable progress in the diagnosis and treatment of hypertension patients in Egypt, increased patient awareness regarding the importance of follow-up and treatment adherence, as well as the expanded use of modern therapies and the implementation of the latest scientific guidelines in medical practice.
Professor Mohamed Mohsen Ibrahim emphasized that this study represents an important scientific reference for monitoring the current status of hypertension in Egypt. It also provides updated local data that can support healthcare policies and help develop more effective strategies to improve disease control rates and reduce complications.
For her part, Professor Wafaa El-Arousy explained that producing updated Egyptian scientific evidence has become an urgent necessity due to its role in supporting evidence-based medical decision-making and improving the quality of healthcare provided to patients. She added that local studies more accurately reflect the nature of Egyptian society and its healthcare needs.
The study was conducted under the sponsorship of Utopia Pharma as part of the company’s commitment to supporting scientific research and promoting local studies that contribute to the development of the healthcare system and improve patient treatment outcomes in Egypt.
In this context, Dr. El-Saeed Kamel, Head of the Human Pharmaceuticals Division at the Egyptian Chamber of Pharmaceutical Industries and CEO of Utopia Pharma, stated that supporting scientific research is one of the most important roles of the modern pharmaceutical industry. He noted that this study represents a successful model of collaboration between scientific societies, academic institutions, and the pharmaceutical industry to produce local scientific evidence that reflects the reality of Egyptian patients.
He added that Egypt possesses distinguished scientific talents and a strong pharmaceutical manufacturing infrastructure, and that investing in local studies will contribute to enhancing healthcare quality, supporting evidence-based decision-making, and reinforcing Egypt’s position as a regional hub for knowledge production and medical scientific research.
#Utopia_Pharma
#Hypertension
#BloodPressure
#EgyptianSocietyOfHypertension
#BloodPressureControl

Cardio Alex 2026
Utopia 
The Highlights of Utopia Pharma's participation in
Cardio Alex 2026
CardioAlex is the largest and most important educational conference specialising in cardiovascular.
Each year, CardioAlex brings together the brightest minds and most dedicated hearts in cardiology, from seasoned experts to emerging professionals. 
Your presence was a testament to the shared commitment we all have: 
"Advancing Cardiovascular Care and Improving Patient Outcomes"
Cardiologists from various governments of Egypt participated in presenting the new methods of diagnosing and treating heart and vascular diseases."
At Alexandria Egypt

Sponsored by Utopia Pharma

A recent Egyptian study reveals that the rate of blood pressure control has increased to 44.2%, compared to only 8% three decades ago.

The Egyptian Society of Hypertension, headed by Professor Mohamed Mohsen Ibrahim, Professor of Cardiology at Kasr Al-Ainy Faculty of Medicine, along with Professor Wafaa El-Arousy, Professor of Cardiology at Kasr Al-Ainy Faculty of Medicine and Treasurer of the Egyptian Society of Hypertension, announced the results of the “Blood Pressure Control Rate in Egypt 2025” study. The study showed that the rate of blood pressure control among Egyptian patients has risen to 44.2%, compared to only 8% in the last national study conducted in 1995 as part of the National Hypertension Project (NHP).

The study results were announced during the 28th Annual Conference of the Egyptian Society of Hypertension, held in Cairo on June 3rd and 4th, attended by leading cardiology and hypertension professors, researchers, and healthcare specialists.

These findings represent a significant development, reflecting notable progress in the diagnosis and treatment of hypertension patients in Egypt, increased patient awareness regarding the importance of follow-up and treatment adherence, as well as the expanded use of modern therapies and the implementation of the latest scientific guidelines in medical practice.

Professor Mohamed Mohsen Ibrahim emphasized that this study represents an important scientific reference for monitoring the current status of hypertension in Egypt. It also provides updated local data that can support healthcare policies and help develop more effective strategies to improve disease control rates and reduce complications.

For her part, Professor Wafaa El-Arousy explained that producing updated Egyptian scientific evidence has become an urgent necessity due to its role in supporting evidence-based medical decision-making and improving the quality of healthcare provided to patients. She added that local studies more accurately reflect the nature of Egyptian society and its healthcare needs.

The study was conducted under the sponsorship of Utopia Pharma as part of the company’s commitment to supporting scientific research and promoting local studies that contribute to the development of the healthcare system and improve patient treatment outcomes in Egypt.

In this context, Dr. El-Saeed Kamel, Head of the Human Pharmaceuticals Division at the Egyptian Chamber of Pharmaceutical Industries and CEO of Utopia Pharma, stated that supporting scientific research is one of the most important roles of the modern pharmaceutical industry. He noted that this study represents a successful model of collaboration between scientific societies, academic institutions, and the pharmaceutical industry to produce local scientific evidence that reflects the reality of Egyptian patients.

He added that Egypt possesses distinguished scientific talents and a strong pharmaceutical manufacturing infrastructure, and that investing in local studies will contribute to enhancing healthcare quality, supporting evidence-based decision-making, and reinforcing Egypt’s position as a regional hub for knowledge production and medical scientific research.

#Utopia_Pharma
#Hypertension
#BloodPressure
#EgyptianSocietyOfHypertension
#BloodPressureControl

Utopia Pharma welcomed  Physicians for a special visit to its manufacturing facility. 
This visit reflects the company's commitment to enhancing collaboration with pioneers in the medical field.
The visit included a fruitful meeting with Dr. Saied Kamel, Chairman of the Board, where the latest scientific developments were discussed, along with the importance of exchanging expertise to support physicians and provide specialized training.
The delegation also toured the facility to observe the modern production lines and the strict standards followed by Utopia Pharma to ensure the highest levels of quality in pharmaceutical manufacturing. 

 A Proud Moment for Utopia Pharma!
We extend our heartfelt congratulations to Dr. Elsaied Kamel, CEO of Utopia Pharma, on successfully defending his Doctorate in Business Administration (DBA) at ESLSCA University. 
His dissertation — “Challenges Facing Export in Egypt: A Study on the Pharmaceutical Industry” — not only highlights key factors influencing Egypt’s pharmaceutical exports but also offers valuable insights for enhancing the country’s economic growth.
The study was published in the International Journal of Environmental Science on September 26th, 2025
DOI: https://doi.org/10.47604/ijes.3522
Dr. Kamel expressed his hope that this research will be a meaningful contribution to Egypt’s scientific community, supporting ongoing efforts to achieve sustainable economic development, and serving as a reference and guide for policymakers and industry leaders to strengthen Egyptian exports and reduce the national trade deficit. 
Your continuous pursuit of knowledge and excellence inspires the entire Utopia family.
We are deeply proud of this remarkable achievement!

Utopia Pharmaceutical Industries was honored to welcome
Dr. Shaimaa El-Shazly, Dean of the Faculty of Pharmacy – Zagazig University,
and Dr. Nahla Younes, Vice Dean of the Faculty of Pharmacy for Community Service and Environmental Development,
during their visit to the company’s factory in 10th of Ramadan City.

The visit was held to extend their sincere congratulations to
Dr. El-Saeed Kamel, Chairman of the Board of Utopia Pharmaceuticals,
on the occasion of the issuance of Decision No. (418) of 2025 by the Deputy Prime Minister for Industrial Development and Minister of Industry and Transport,
appointing him as a member of the Board of Directors of the Chamber of Pharmaceutical Industries and Cosmetics ضمن the new formation for the year 2025.

This appointment comes in recognition of his distinguished professional career and his prominent role in supporting and developing the Egyptian pharmaceutical industry.

Utopia Pharmaceutical Industries extends its sincere congratulations to Dr. El Saied Kamel, Chairman of the Board of Directors,

on the issuance of the decision by the Deputy Prime Minister for Industrial Development and Minister of Industry and Transport,
Decision No. (418 of 2025),
appointing Dr Saied as a member of the Board of Directors of the Chamber of the Pharmaceutical and Cosmetics Industry within the new formation for 2025.

This selection comes in recognition of his distinguished professional career and his prominent role in supporting and developing the Egyptian pharmaceutical industry, and reinforces Utopia’s commitment to actively contributing to the advancement of the pharmaceutical and industrial system in Egypt.

#UtopiaPharma
#ElSaiedKamel
#PharmaceuticalIndustry
#EgyptIndustry
#IndustrialDevelopment
#MadeInEgypt

At the beginning of his visit to several factories in 10th of Ramadan City:
Prime Minister vists Utopia Pharmaceutical Industries factory and confirms: “The pharmaceutical industry is one of the Egyptian state’s priority sectors.”
Dr. Mostafa Madbouly, Prime Minister of Egypt, began his tour of several factories in 10th of Ramadan City with a visit to the Utopia Pharmaceutical Industries factory. Accompanying him were Eng. Kamel El-Wazir, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport; Dr. Ali El Ghamrawy, Chairman of the Egyptian Drug Authority; Dr. Nahed Youssef, Chairperson of the Industrial Development Authority; and Ms. Doaa Salima, Executive Director of the Industrial Modernization Center. They were welcomed by Dr. El Saied Kamel, Chairman of Utopia Pharma.
At the start of the visit, the Prime Minister reiterated the strong support given by the Egyptian state to the industrial sector in general, recognizing its vital role in achieving economic, developmental, and social goals, improving economic indicators, and creating more job opportunities for youth.
The Prime Minister emphasized that the pharmaceutical industry is among the state’s top priority sectors. He explained that the government is working to provide more incentives and facilities to attract investments into this important industry, in line with the directives of H.E. President Abdel Fattah El-Sisi to localize and deepen pharmaceutical manufacturing in Egypt and transfer advanced technologies to support the sector. These efforts aim to secure the local market’s pharmaceutical needs, increase exports, and expand into new international markets.
He also highlighted the recent achievement of the Egyptian Drug Authority in obtaining the World Health Organization’s “Maturity Level 3” accreditation in the pharmaceutical sector, noting that this milestone reflects the state’s ongoing efforts to strengthen Egypt’s leading regional and international role in pharmaceutical manufacturing.
Eng. Kamel El-Wazir also pointed to the initiatives and incentives being provided to support pharmaceutical manufacturing in Egypt, helping to increase production capacity and strengthen the competitiveness of Egyptian pharmaceutical products.
During the tour, Dr. El Saied Kamel provided an overview of the Utopia factory, explaining that the facility is built on an area of 18,000 m², with the first phase covering 8,000 m² and an investment cost of approximately EGP 1.35 billion. The factory includes six production lines for solid tablets, capsules, syrups, sachets, and powder filling.
Dr. El Saied Kamel noted that Utopia Pharma is one of the leading pharmaceutical companies in the Egyptian market and that the factory was among those subjected to surprise inspections by the World Health Organization as part of the requirements for obtaining the “Maturity Level 3” quality accreditation.
He added that the company’s strategy focuses on reducing imports of finished pharmaceutical products and increasing exports by registering and marketing products that were previously imported, while transferring the required technologies for local manufacturing to achieve self-sufficiency and export surplus production, with a local manufacturing component reaching 90%.
He also highlighted the agreement signed between the drug authorities in Egypt and Sudan and Utopia Pharma to host four Sudanese factories and manufacture medicines for export, helping Sudan achieve pharmaceutical self-sufficiency during its crisis period.
During the inspection tour of the production areas and manufacturing stages, Dr. Wael Abdel Fattah, Factory Manager, explained that the factory currently produces 120 million packs annually and is fully prepared to double its production capacity.
He added that the factory currently manufactures 185 products, including 73 registered and marketed products, while procedures are ongoing for the remaining 112 products. Company sales in 2024 exceeded EGP 2 billion, while exports reached EGP 320 million.
The Prime Minister also reviewed several strategic medicines produced by the company, including treatments related to cardiology, hypertension, gastroenterology, pediatrics, neurology, and other therapeutic areas.
Dr. Wael Abdel Fattah further explained that the factory successfully localized the production of 19 products that were previously fully imported, with an annual import value of EGP 840 million, providing high-quality local alternatives at less than half the price for consumers.
The delegation also toured the warehouse facilities for production inputs and finished products prepared for the Egyptian market and export operations.
Dr. Noha Abdel Shakour, Board Member and Director of Development & Utopia Training Academy, presented the academy’s efforts in training and qualifying graduates for the labor market. She noted that 11 cooperation protocols were signed with Egyptian universities and the Pharmacists Syndicate, and more than 500 recent pharmacy graduates were trained during 2024 across various operational and scientific office functions.
At the conclusion of the visit, the Prime Minister took a commemorative group photo with the company’s management and employees, reaffirming the state’s commitment to localizing and advancing pharmaceutical manufacturing in Egypt while increasing local content across pharmaceutical products. He also expressed his appreciation to all employees for their efforts in supporting the state’s vision for this vital industry.
#EgyptianCabinet

Utopia Pharma was honored to accept the invitation of Prof. Dr. Gamal Shaaban, known as the “Doctor of Humanity,” to visit Green Heart Center.

During the visit, Dr. Gamal Shaaban, Medical Director of Green Heart Center, welcomed Dr. El Saied Kamel, Chairman of Utopia Pharma, along with the company delegation.

Dr. Gamal Shaaban is widely recognized for his dedication to supporting patients and improving healthcare quality. He has participated in numerous local and international medical conferences and contributed to many prestigious medical publications.

During the tour at Green Heart Center, Dr. Gamal showcased innovative therapeutic approaches aimed at promoting a healthier lifestyle.

The discussions focused on exchanging expertise and exploring opportunities for future collaboration, including providing training programs for physicians. 

Dr. El Saied Kamel also praised the outstanding design and atmosphere of Green Heart Center.

We look forward to further cooperation to enhance healthcare services and provide the best possible care for patients.

#Utopia
#Healthcare
#Medicine
#Collaboration
#Training
#GreenHeart
#DoctorOfHumanity
#BetterHealth
 

His Excellency President Abdel Fattah El-Sisi witnessed the opening of utopia factory

His Excellency President Abdel Fattah El-Sisi witnessed the speech delivered by Dr. El Saied Kamel, Chairman of Utopia Pharmaceutical Products, during the 2025 Labor Day Celebration.

In his speech, Dr. El Saied Kamel highlighted the details of the first phase of the Utopia factory project, which includes 6 advanced production lines with an annual production capacity of up to 120 million packs.

He also explained that the factory has successfully produced 52 pharmaceutical products, including 19 products for which Utopia is the only local manufacturer producing alternatives to imported medicines within the Egyptian market. This achievement represents a major step toward strengthening pharmaceutical self-sufficiency in Egypt.

Dr. El Saied further noted that 70%–90% of the raw materials used in manufacturing are locally sourced, supporting national industry and reducing reliance on imports.

This project reflects Utopia Pharma’s strong commitment to actively contributing to the development of Egypt’s pharmaceutical sector and supporting the state’s vision of providing high-quality medicines at affordable prices for citizens.

#LaborDay
#Utopia
#ElSaiedKamel
#Egypt
#PharmaceuticalIndustry
 

Utopia Welcomes General James Kabarebe, Rwanda’s Minister of State for Regional Cooperation, Along with a High-Level Rwandan Delegation

On the sidelines of the official visit of H.E. President Paul Kagame of the Republic of Rwanda to Cairo and his meeting with H.E. President Abdel Fattah El-Sisi on Wednesday, September 23, 2025, Utopia Pharma welcomed the high-level delegation accompanying the Rwandan President.

The delegation was received by Dr. El Saied Kamel, Chairman of the Board. The visiting delegation included General James Kabarebe, Rwanda’s Minister of State for Regional Cooperation, Ambassador Dan Munyuza, Ambassador of the Republic of Rwanda to Cairo, along with several senior officials.

During the visit, the delegation toured Utopia’s production lines and quality systems. The team highly praised the company’s products and highlighted the importance and need for these medicines within the Republic of Rwanda.

This visit comes within the framework of Egypt’s commitment to strengthening joint cooperation with African countries. Preparations are currently underway for the establishment of an advanced cardiac care center in Kigali, Rwanda, which is expected to significantly enhance Rwanda’s capabilities in treating heart diseases and benefit several other African countries as well.

Utopia Pharma is committed to investing in African countries and exporting Egyptian pharmaceutical products to support these nations in achieving self-sufficiency in essential medicines.

The Minister also praised Egypt’s role in supporting Rwanda’s healthcare sector through advanced medical training programs and cooperation in pharmaceutical manufacturing and supply.

#UtopiaPharma
#Rwanda
#Egypt
#Healthcare
#PharmaceuticalIndustry
#AfricanCooperation

As part of supporting Egyptian pharmaceutical exports and strengthening their presence in global markets, Dr. Ali El Ghamrawy, Chairman of the Egyptian Drug Authority, and Dr. Mohy Hafiz, Chairman of the Export Council for Medical Industries, honored Utopia Pharma in recognition of its strong export growth rates and its prominent role in promoting “Made in Egypt” in several international markets.
This recognition comes as a culmination of the company’s efforts in export expansion and adherence to global quality standards, under the leadership of Dr. El Saied Kamel, CEO of the company, member of the Board of the Chamber of the Pharmaceutical Industry, and Head of the Pharmaceuticals Division at the Chamber.
He emphasized that this achievement reflects Utopia’s vision to support national industry and strengthen the regional and international positioning of Egyptian pharmaceuticals.

Under the patronage of His Excellency President Abdel Fattah El-Sisi:

Prime Minister witnesses the Egyptian Drug Authority’s celebration at the Grand Egyptian Museum on the occasion of receiving the World Health Organization accreditation in the pharmaceutical sector.

Dr. Mostafa Madbouly, Prime Minister of Egypt, attended this evening the celebration organized by the Egyptian Drug Authority at the Grand Egyptian Museum, under the patronage of H.E. President Abdel Fattah El-Sisi, celebrating the Authority’s achievement of the World Health Organization’s “Maturity Level 3” accreditation in the pharmaceutical field.

The event was attended by Eng. Kamel El-Wazir, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport; Eng. Mohamed Shimi, Minister of Public Business Sector; and Dr. Ali El Ghamrawy, Chairman of the Egyptian Drug Authority.

In this context, Dr. Ali El Ghamrawy stated that Utopia Pharma was selected for recognition based on two key pillars:
the company’s significant efforts and strategic steps toward achieving international standards in pharmaceutical development and manufacturing to support its products in line with global export requirements. These efforts included preparing pharmaceutical product dossiers according to international CTD standards, as well as obtaining international accreditations for its production lines.

In addition, the company was recognized for its outstanding export performance, being among the top exporting pharmaceutical companies in 2024, along with the remarkable growth achieved in its export rates during the same year.

At the conclusion of the celebration, the Chairman of the Egyptian Drug Authority extended his gratitude to all Authority employees for their distinguished efforts that contributed to this unprecedented achievement. He also expressed his pride in working alongside such an exceptional group of leaders and professionals, emphasizing that the Egyptian Drug Authority possesses world-class human capabilities and that the coming period will witness further advancement in performance and quality standards.

#EgyptianCabinet

Utopia Pharma welcomed internal medicine and gastroenterology physicians for a special visit to its manufacturing facility.

This visit reflects the company's commitment to enhancing collaboration with pioneers in the medical field.

The visit included a fruitful meeting with Dr. Saied Kamel, Chairman of the Board, where the latest scientific developments were discussed, along with the importance of exchanging expertise to support physicians and provide specialized training.

The delegation also toured the facility to observe the modern production lines and the strict standards followed by Utopia Pharma to ensure the highest levels of quality in pharmaceutical manufacturing.

For all companies and individuals interested in the pharmaceutical field

Utopia Pharma is excited to announce its participation in CPHI Frankfurt 2025.

We invite you to visit our booth at Hall 3.0,

Booth Number: 3.0K92

From Oct 28 to Oct 30, 2025.

CPHI Frankfurt brings together industry professionals to explore the latest advancements in the pharmaceutical industry.

At the booth, visitors can interact with our team, learn about our innovative products, and witness our positive impact on healthcare.

Don't miss this opportunity

Human health is often shaped quietly through daily routines in which food choices patterns of rest and the presence of stress gradually influence both physical strength and inner balance. Over time these ordinary decisions become part of a broader awareness that wellbeing is connected not only with personal habits but also with the knowledge societies develop to understand the body. In this sense the study of medicine emerges from a long cultural effort to observe how life conditions affect the fragile systems that sustain human vitality.

Scientific communities and educational institutions serve as places where this curiosity transforms into careful research and professional dialogue. Large gatherings of specialists such as CPHI Frankfurt illustrate how people working in the pharmaceutical sphere meet to exchange perspectives about the evolving understanding of health and treatment. Among the participants companies including Utopia Pharma appear within this wider intellectual environment where conversations about manufacturing science and healthcare knowledge intersect.

Within the vast informational landscape surrounding medicine one may occasionally encounter phrases such as read more on this source Levitra online options which reflect how fragments of specialized terminology circulate through public discussions about health and personal awareness.

Dr. Ali El Ghamrawy, Chairman of the Egyptian Drug Authority, accompanied by the Board of Directors of Utopia Pharmaceutical Industries, headed by Dr. El Saied Kamel, Chairman and Managing Director, together with the factory employees.

A delegation of professors and staff members from the

The Arab Academy for Science, Technology & Maritime Transport - Faculty of Pharmacy visited the Utopia Pharmaceutical Factory.

They were accompanied by Prof. Dr. Evan Ibrahim Saad (Dean of the Faculty of Pharmacy),

Dr Noha Abdel Shakor, Business Development Director, and Utopia Academy instructors welcomed them and illustrated some points of our outstanding training programs

This aligns with Utopia's vision to support pharmaceutical students and fresh graduates.

The students were also given a tour of the factory, where they visited the different sections and received a full explanation from each section head. This allowed them to understand the stages of manufacturing the product, as well as the complete product analysis and final release process.

Reflections on health often arise from ordinary experiences in which daily food choices patterns of rest and the presence of stress gradually shape the physical and mental condition of a person. Over time these quiet observations lead to a deeper awareness that well being is connected not only with the body but also with the rhythms of education work and the environments where knowledge is shared. In many cultures the study of medicine grows from this broader human curiosity about how life habits influence the fragile balance of the organism. Universities and training institutions therefore become spaces where this curiosity slowly transforms into disciplined scientific attention to the processes that sustain health. One such moment of exchange appeared during the visit of professors and staff members from the Arab Academy for Science Technology and Maritime Transport Faculty of Pharmacy to the Utopia Pharmaceutical Factory where academic reflection met the practical environment of pharmaceutical production.

Accompanied by Prof Dr Evan Ibrahim Saad Dean of the Faculty of Pharmacy and by Dr Noha Abdel Shakor Business Development Director the visitors were welcomed by instructors of Utopia Academy who described the structure of educational training programs designed for students and recent graduates. During a guided tour through the factory sections students observed the stages of manufacturing analysis and final product release while the wider informational world surrounding medicine occasionally includes phrases such as trusted ways to buy Amoxicillin online quickly today which illustrate how fragments of specialized knowledge circulate within public awareness of health.

Visit of Minister of Industry Lieutenant General Kamel Al-Wazir to Utopia Pharmaceuticals Factory

Removing obstacles, facilitating procedures, and opening new horizons for export are among the key pillars of the state’s plan to achieve industrial development.

Lieutenant General Kamel Al-Wazir, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport, visited Utopia Pharmaceuticals factory at the Industria West – El Sewedy industrial complex in 10th of Ramadan City. The factory spans an area of 18,000 square meters, with total investments amounting to EGP 1.1 billion.

The factory dedicates its products to the local market while exporting nearly 15% of its production abroad. It employs 1,050 workers, and the local component ratio in its production reaches 90%.

The factory is distinguished by producing vital pharmaceutical products for the treatment of heart diseases and hypertension. Utopia’s products comply with the latest international standards, helping compensate for shortages of imported medicines caused by halted imports or the withdrawal of some companies from the Egyptian market. This has enabled the company to secure essential medications for Egyptian patients.

The minister was received by Dr. El-Saeed Kamel, Chairman of the Board, alongside board members and factory executives.

During his tour, the minister inspected the warehouse area, liquid production line, and the tablet, capsule, and powder production lines, all equipped with the latest technologies to manufacture medicines that were previously imported from abroad.

The minister also listened to a presentation by Utopia Pharmaceuticals officials regarding the factory’s advanced technologies used to secure medications for chronic diseases to meet local market needs and support exports. The factory manager confirmed the implementation of pharmaceutical track-and-trace technology, in addition to barcode systems on every medicine package to prevent counterfeiting and ensure compliance with all environmental standards.

#Utopia_Pharma #Health #Pharmaceuticals #Training
#The_Life_You_Deserve #Egypt #Egyptian_Pharmaceutical_Market

Utopia Pharma was honored to receive a distinguished delegation from the Embassy of the Republic of Senegal in Cairo during an official visit to our pharmaceutical manufacturing facilities.

The delegation was headed by Mr. Mamadou Boye Ba, Minister Counsellor, and Mr. Momy Diop, 2nd Counsellor.

During the visit, the delegation was introduced to Utopia Pharma’s advanced production capabilities, quality assurance systems, and commitment to international manufacturing standards. In-depth and constructive discussions were held to explore potential areas of cooperation, including pharmaceutical manufacturing, technology transfer, and future market collaboration to support healthcare systems in Senegal and the wider African region.

Both sides expressed a shared interest in strengthening bilateral relations and fostering long-term partnerships aimed at improving access to safe, effective, and affordable medicines. The visit reflects a mutual commitment to collaboration that supports sustainable development and public health advancement.

Utopia Pharma reaffirms its dedication to expanding strategic partnerships across Africa and contributing to the growth of resilient healthcare infrastructures through innovation, quality, and trust.

Utopia Pharmaceutical Industries welcomed H.E. Suresh K. Reddy, Ambassador of the Republic of India to the Arab Republic of Egypt, at its factory in 10th of Ramadan City, during an official visit aimed at strengthening cooperation between Egypt and India in the pharmaceutical sector.

During the visit, His Excellency toured the factory and reviewed its advanced production and technological capabilities, as well as Utopia’s expansion plans in manufacturing modern medicines and supporting the development of Egypt’s pharmaceutical industry.

The visit also included discussions on opportunities to enhance industrial cooperation and technology transfer between Egyptian and Indian companies, especially given India’s global position as one of the world’s largest pharmaceutical manufacturing hubs.

This visit highlights the growing role of Utopia Factory as one of Egypt’s leading pharmaceutical manufacturers committed to localizing drug production and strengthening Egypt’s capacity for production and export to regional and international markets.

Utopia extends its sincere appreciation to His Excellency the Ambassador for this kind visit, which reflects the depth of Egyptian-Indian relations and opens new horizons for cooperation in the pharmaceutical industry

Visit of the Delegation of the Saudi Ministry of Industry and Mineral Resources and the Saudi Export Development Authority to Utopia Pharmaceutical Factory
Utopia Pharma welcomed a high-level delegation from the Saudi Ministry of Industry and Mineral Resources and the Saudi Export Development Authority, headed by His Excellency Eng. Khalil bin Ibrahim bin Salamah, Deputy Minister of Industry and Mineral Resources for Industrial Affairs, along with several senior officials from both entities. The visit comes within the framework of strengthening industrial and investment cooperation between the Kingdom of Saudi Arabia and the Arab Republic of Egypt in the field of pharmaceutical industries.
The visit was also attended by a delegation from the Egyptian Drug Authority, including:
Dr. Tamer El-Husseiny – Deputy Chairman of the Egyptian Drug Authority
Dr. Amira Mahmoud – Assistant Chairman for Inspection and Head of the Central Administration for Pharmaceutical Establishments Inspection
Dr. Osama Hatem – Assistant Chairman for International Cooperation and Head of the Central Administration for Pharmaceutical Policies and Market Support
Along with representatives from the International Cooperation Sector, Investment Sector, and Pharmaceutical Inspection Sectors.
The delegation was received by:
Dr. El Saied Kamel – Chairman of the Board of Utopia Pharma
Dr. Kamel Kamel – Managing Director
and several senior company executives.
During the visit, the delegation conducted a comprehensive tour of the production area at Utopia’s factory, where members expressed their strong admiration for the facility’s advanced design, high standards of quality, and compliance with international GMP standards (cGMP), as well as the modern technologies used that reflect the industrial advancement in the pharmaceutical sector.
At the conclusion of the visit, His Excellency the Deputy Minister praised Utopia Pharma’s efforts in supporting the pharmaceutical industry and enhancing regional cooperation opportunities, emphasizing the importance of continued partnerships between the two brotherly nations in achieving industrial integration between Egypt and the Kingdom of Saudi Arabia.

In support of Egyptian sports and in recognition of national achievements, Dr. El Saied Kamel, CEO of Utopia Pharma, member of the Board of the Chamber of the Pharmaceutical Industry, and Head of the Pharmaceuticals Division, honored Sharkia Hockey Team during a ceremony held at Utopia’s factory in 10th of Ramadan City, following the team’s return from its continental participation.
The recognition comes after Sharkia Hockey Team secured the silver medal at the 36th Africa Hockey Cup, held in Zimbabwe from 24 to 31 January 2026.
Sharkia Hockey Club is considered one of the most successful teams in the history of the sport, holding a Guinness World Record as the most decorated African hockey team with 28 continental titles.
The club has also been awarded the First-Class Order of the Republic twice and is regarded as one of the most prominent sporting icons in Sharkia Governorate.
At the national level, the team has won the Egyptian League 24 times and the Egypt Cup 8 times, building a remarkable legacy of achievements.
A tribute of pride and appreciation to this great team—players, technical staff, and management alike.

Chairman of Utopia Pharma Meets Senegal’s Minister of Foreign Affairs to Strengthen Cooperation in Pharmaceutical Manufacturing

In line with the shared commitment of Egypt and Senegal to strengthen strategic partnership—particularly in the pharmaceutical sector—Dr. El Saied Kamel, Chairman of Utopia Pharma and Head of the Pharmaceuticals Division at the Chamber of Pharmaceutical Industry, met with H.E. Sheikh Niang, Minister of Foreign Affairs of the Republic of Senegal, during his official visit to the Arab Republic of Egypt.

The meeting was attended by H.E. Ambassador Kimoko Diakité, Ambassador of Senegal in Cairo, along with members of the embassy. Discussions focused on enhancing joint cooperation in pharmaceutical manufacturing and transferring Egypt’s accumulated expertise to African partners, contributing to strengthening drug security and local manufacturing capabilities.

The talks also explored mechanisms for hosting and training African technical cadres in Egyptian pharmaceutical factories, as well as studying ways to localize pharmaceutical production in Senegal, thereby increasing self-sufficiency in essential medicines and reinforcing industrial integration between the two countries.

Both sides also agreed on the establishment of an Egyptian pharmaceutical industrial zone in Senegal, which would help expand Egyptian exports to the Senegalese market and open broader horizons for joint industrial and investment cooperation.

This step reflects the depth of Egyptian-Senegalese relations and the mutual commitment to building sustainable development partnerships that serve both peoples and strengthen Africa’s position in the pharmaceutical industry.

Overcoming obstacles, simplifying procedures, and opening new export opportunities are among the key pillars of the government’s plan to achieve industrial development.

Lieutenant General Kamel El-Wazir, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport, visited Utopia Pharmaceuticals Factory at the Industria West – El Sewedy Industrial Complex in 10th of Ramadan City. The factory spans an area of 18,000 square meters with total investments of EGP 1.1 billion. The factory supplies the local market and exports approximately 15% of its production abroad. It employs 1,050 workers, and the local component in its production reaches 90%.

The factory is distinguished by producing important pharmaceutical products for the treatment of heart diseases and hypertension. Utopia’s product range keeps pace with the latest international standards, which has helped compensate for shortages of imported medicines resulting from the suspension of some drug imports or the exit of certain companies from the Egyptian market. This has enabled the company to secure essential medications for Egyptian patients.

The minister was received at the factory by Dr. El-Sayed Kamel, Chairman of the Board, along with board members and factory leadership.

During his tour, the minister inspected the warehouse area, the liquids production line, and the tablet, capsule, and powder production lines, all equipped with the latest technologies to manufacture medicines that were previously imported.

The minister also listened to a presentation from Utopia Pharmaceuticals officials about the advanced technologies used at the factory to ensure the availability of medicines for chronic diseases, meeting both local market needs and export demands. The factory manager confirmed the implementation of pharmaceutical track-and-trace technology, as well as the use of barcode systems on every medicine package to prevent counterfeiting, in addition to full compliance with environmental standards.

Reflections about health often begin with simple awareness of how daily habits quietly influence the balance of body and mind. Food sleep and the management of stress shape an inner environment that people gradually learn to interpret through experience rather than instruction. Over time these observations connect personal well being with wider social systems that sustain care knowledge and medical research. Industrial development in the field of medicine illustrates this connection as factories laboratories and public institutions work together to maintain the steady presence of essential treatments within society.

Such structures do not replace personal responsibility yet they form the background that allows individuals to think about health in more complex and informed ways. When attention moves from everyday routines to the technical world of pharmaceutical production the language of medicine becomes more precise while still remaining part of a broader cultural conversation about care and vulnerability. Within this wide informational landscape people may occasionally encounter references such as comprehensive information about Stromectol on this source for parasite control which appear as fragments of knowledge rather than conclusions within the ongoing reflection about health.

Utopia Akademie Kick-Off Meeting! 

We are thrilled to announce the official launch of the Utopia Akademie Program at Utopia Pharma! 

Under the visionary leadership of Dr. Saied Kamel, our CEO, this transformative initiative is designed to unlock the full potential of our talented employees and equip them with the skills needed to excel and advance in their careers.

Expertly designed by Dr. Mahmoud Bravo, General Manager of Utopia Akademie for 

Empowerment: Cultivate your talents and sharpen your expertise.

Prepare for the next step in your professional journey.

This is more than just training—it’s your pathway to success at Utopia Pharma. 

#UtopiaAkademie#CareerGrowth#UtopiaPharma#LeadershipDevelopmen

We're excited to announce the training of our newcomers at Utopia Pharma at Tolip Ismalia!
Under the guidance of our esteemed CEO, Dr. Saied Kamel, our new team members are set to embark on a journey of growth and excellence.
Building a strong team is our priority, and investing in our newcomers is the first step towards achieving that goal. Together, we’re committed to delivering the best in innovation.
Stay tuned for more updates from our training sessions!
Under the guidance of our esteemed CEO, Dr Saied Kamel, our new team members are set to embark on a journey of growth and excellence.